US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist

0.540
+0.001+0.19%

Close Oct 18 16:00 ET

15.07MMarket Cap-696P/E (TTM)

ImmunoPrecise Antibodies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jul 31, 2024

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-229.84%-1.82M

78.59%-4.25M

-18.31%-2.64M

81.21%-666K

89.73%-384K

94.64%-553K

-99.91%-19.83M

-25.01%-2.23M

31.26%-3.55M

-85.88%-3.74M

Net income from continuing operations

-17.07%-4M

-2.32%-27.18M

-251.82%-18.05M

37.47%-2.94M

62.22%-2.78M

63.59%-3.42M

-58.96%-26.56M

-10.44%-5.13M

-22.84%-4.7M

-46.74%-7.35M

Operating gains losses

37.17%155K

106.88%13K

-740.00%-84K

-28.36%48K

71.93%-64K

727.78%113K

66.37%-189K

-103.64%-10K

111.78%67K

-241.61%-228K

Depreciation and amortization

-6.63%1.4M

-14.21%5.74M

-20.37%1.58M

-22.45%1.31M

-7.58%1.35M

-3.61%1.49M

77.37%6.69M

114.15%1.98M

77.87%1.69M

56.24%1.46M

Deferred tax

-198.61%-645K

-91.47%-1.77M

-376.40%-1.19M

35.66%-166K

-27.39%-200K

17.24%-216K

-175.60%-926K

72.89%-250K

-130.60%-258K

3.09%-157K

Other non cash items

-40.00%3K

-36.67%19K

-85.19%4K

--5K

66.67%5K

-64.71%30K

35.00%27K

--0

Change In working capital

71.12%1.1M

172.37%2.37M

91.08%-174K

268.04%899K

-53.95%1M

121.71%644K

-662.89%-3.28M

-210.10%-1.95M

83.46%-535K

60.95%2.18M

-Change in receivables

272.05%874K

55.37%-241K

70.37%-264K

-54.07%497K

109.69%34K

-33.68%-508K

-312.60%-540K

-1,663.16%-891K

304.15%1.08M

-169.92%-351K

-Change in inventory

643.64%299K

44.86%-102K

434.15%411K

-381.32%-438K

-766.67%-20K

-311.54%-55K

63.07%-185K

38.81%-123K

53.81%-91K

130.00%3K

-Change in prepaid assets

-267.43%-293K

593.33%624K

8.37%440K

104.00%34K

-103.82%-25K

245.83%175K

111.66%90K

361.36%406K

22.73%-850K

370.25%654K

-Change in payables and accrued expense

119.01%530K

159.04%983K

49.58%-479K

233.16%783K

-81.07%437K

109.94%242K

-213.89%-1.67M

-180.58%-950K

-72.94%-588K

236.44%2.31M

-Change in other working capital

-138.99%-308K

213.42%1.11M

28.24%-282K

126.14%23K

231.51%576K

1,485.96%790K

-802.16%-976K

-160.55%-393K

91.75%-88K

-205.29%-438K

Cash from discontinued investing activities

Operating cash flow

-229.84%-1.82M

78.59%-4.25M

-18.31%-2.64M

81.21%-666K

89.73%-384K

94.64%-553K

-99.91%-19.83M

-25.01%-2.23M

31.26%-3.55M

-85.88%-3.74M

Investing cash flow

Cash flow from continuing investing activities

-33.50%-263K

20.54%-1.56M

-150.23%-1.11M

125.22%57K

74.17%-312K

-121.35%-197K

62.23%-1.97M

89.15%-444K

65.96%-226K

-988.29%-1.21M

Net PPE purchase and sale

-93.38%-263K

6.56%-1.4M

-143.94%-1.13M

167.35%165K

57.22%-299K

-52.81%-136K

-40.24%-1.5M

-225.35%-462K

48.20%-245K

-529.73%-699K

Net intangibles purchase and sale

----

--0

----

--0

----

Net business purchase and sale

--0

75.34%-146K

--0

---146K

83.97%-592K

100.49%18K

--0

---610K

Net investment purchase and sale

--0

51.25%121K

--0

-40.98%36K

--85K

--80K

--0

--19K

--61K

Net other investing changes

----

-452.50%-141K

--16K

---108K

----

115.44%40K

--0

----

Cash from discontinued investing activities

Investing cash flow

-33.50%-263K

20.54%-1.56M

-150.23%-1.11M

125.22%57K

74.17%-312K

-121.35%-197K

62.23%-1.97M

89.15%-444K

65.96%-226K

-988.29%-1.21M

Financing cash flow

Cash flow from continuing financing activities

765.68%2.7M

264.41%1.02M

394.75%1.12M

317.38%613K

-259.79%-310K

-166.45%-405K

-121.54%-621K

-112.44%-381K

-452.94%-282K

136.59%194K

Net issuance payments of debt

644.44%2.21M

-0.15%-1.34M

20.94%-302K

15.04%-322K

-1.64%-310K

-49.45%-405K

-38.98%-1.34M

-46.92%-382K

-59.92%-379K

-33.19%-305K

Net common stock issuance

--491K

229.61%2.36M

142,400.00%1.43M

863.92%935K

--0

-81.40%716K

-99.97%1K

-47.85%97K

60.45%499K

Cash from discontinued financing activities

Financing cash flow

765.68%2.7M

264.41%1.02M

394.75%1.12M

317.38%613K

-259.79%-310K

-166.45%-405K

-121.54%-621K

-112.44%-381K

-452.94%-282K

136.59%194K

Net cash flow

Beginning cash position

-57.63%3.55M

-72.16%8.37M

-44.88%6.29M

-59.70%6.1M

-64.74%6.81M

-72.16%8.37M

-28.18%30.05M

-65.50%11.41M

-60.60%15.15M

-52.61%19.32M

Current changes in cash

152.73%609K

78.65%-4.79M

13.99%-2.63M

100.10%4K

78.84%-1.01M

89.06%-1.16M

-83.09%-22.42M

-8.55%-3.06M

30.98%-4.05M

-132.93%-4.75M

Effect of exchange rate changes

61.31%-154K

-104.46%-33K

-806.25%-113K

-42.90%181K

-48.35%297K

-136.90%-398K

62.64%740K

107.92%16K

-36.60%317K

291.67%575K

End cash Position

-41.29%4M

-57.63%3.55M

-44.88%6.29M

-59.70%6.1M

-64.74%6.81M

-72.16%8.37M

-65.50%11.41M

-60.60%15.15M

Free cash flow

-202.90%-2.09M

73.54%-5.64M

-39.84%-3.77M

86.78%-501K

84.61%-683K

93.38%-689K

-90.80%-21.33M

-39.76%-2.7M

34.89%-3.79M

-109.09%-4.44M

Currency Unit

CAD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Jul 31, 2024	(FY)Apr 30, 2024	(Q4)Apr 30, 2024	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-229.84%-1.82M	78.59%-4.25M	-18.31%-2.64M	81.21%-666K	89.73%-384K	94.64%-553K	-99.91%-19.83M	-25.01%-2.23M	31.26%-3.55M	-85.88%-3.74M
Net income from continuing operations	-17.07%-4M	-2.32%-27.18M	-251.82%-18.05M	37.47%-2.94M	62.22%-2.78M	63.59%-3.42M	-58.96%-26.56M	-10.44%-5.13M	-22.84%-4.7M	-46.74%-7.35M
Operating gains losses	37.17%155K	106.88%13K	-740.00%-84K	-28.36%48K	71.93%-64K	727.78%113K	66.37%-189K	-103.64%-10K	111.78%67K	-241.61%-228K
Depreciation and amortization	-6.63%1.4M	-14.21%5.74M	-20.37%1.58M	-22.45%1.31M	-7.58%1.35M	-3.61%1.49M	77.37%6.69M	114.15%1.98M	77.87%1.69M	56.24%1.46M
Deferred tax	-198.61%-645K	-91.47%-1.77M	-376.40%-1.19M	35.66%-166K	-27.39%-200K	17.24%-216K	-175.60%-926K	72.89%-250K	-130.60%-258K	3.09%-157K
Other non cash items	-40.00%3K	-36.67%19K	-85.19%4K	--5K	--5K	66.67%5K	-64.71%30K	35.00%27K	--0	--0
Change In working capital	71.12%1.1M	172.37%2.37M	91.08%-174K	268.04%899K	-53.95%1M	121.71%644K	-662.89%-3.28M	-210.10%-1.95M	83.46%-535K	60.95%2.18M
-Change in receivables	272.05%874K	55.37%-241K	70.37%-264K	-54.07%497K	109.69%34K	-33.68%-508K	-312.60%-540K	-1,663.16%-891K	304.15%1.08M	-169.92%-351K
-Change in inventory	643.64%299K	44.86%-102K	434.15%411K	-381.32%-438K	-766.67%-20K	-311.54%-55K	63.07%-185K	38.81%-123K	53.81%-91K	130.00%3K
-Change in prepaid assets	-267.43%-293K	593.33%624K	8.37%440K	104.00%34K	-103.82%-25K	245.83%175K	111.66%90K	361.36%406K	22.73%-850K	370.25%654K
-Change in payables and accrued expense	119.01%530K	159.04%983K	49.58%-479K	233.16%783K	-81.07%437K	109.94%242K	-213.89%-1.67M	-180.58%-950K	-72.94%-588K	236.44%2.31M
-Change in other working capital	-138.99%-308K	213.42%1.11M	28.24%-282K	126.14%23K	231.51%576K	1,485.96%790K	-802.16%-976K	-160.55%-393K	91.75%-88K	-205.29%-438K
Cash from discontinued investing activities
Operating cash flow	-229.84%-1.82M	78.59%-4.25M	-18.31%-2.64M	81.21%-666K	89.73%-384K	94.64%-553K	-99.91%-19.83M	-25.01%-2.23M	31.26%-3.55M	-85.88%-3.74M
Investing cash flow
Cash flow from continuing investing activities	-33.50%-263K	20.54%-1.56M	-150.23%-1.11M	125.22%57K	74.17%-312K	-121.35%-197K	62.23%-1.97M	89.15%-444K	65.96%-226K	-988.29%-1.21M
Net PPE purchase and sale	-93.38%-263K	6.56%-1.4M	-143.94%-1.13M	167.35%165K	57.22%-299K	-52.81%-136K	-40.24%-1.5M	-225.35%-462K	48.20%-245K	-529.73%-699K
Net intangibles purchase and sale	----	--0	----	----	----	----	--0	----	----	----
Net business purchase and sale	--0	75.34%-146K	--0	--0	--0	---146K	83.97%-592K	100.49%18K	--0	---610K
Net investment purchase and sale	--0	51.25%121K	--0	--0	-40.98%36K	--85K	--80K	--0	--19K	--61K
Net other investing changes	----	-452.50%-141K	--16K	---108K	----	----	115.44%40K	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	-33.50%-263K	20.54%-1.56M	-150.23%-1.11M	125.22%57K	74.17%-312K	-121.35%-197K	62.23%-1.97M	89.15%-444K	65.96%-226K	-988.29%-1.21M
Financing cash flow
Cash flow from continuing financing activities	765.68%2.7M	264.41%1.02M	394.75%1.12M	317.38%613K	-259.79%-310K	-166.45%-405K	-121.54%-621K	-112.44%-381K	-452.94%-282K	136.59%194K
Net issuance payments of debt	644.44%2.21M	-0.15%-1.34M	20.94%-302K	15.04%-322K	-1.64%-310K	-49.45%-405K	-38.98%-1.34M	-46.92%-382K	-59.92%-379K	-33.19%-305K
Net common stock issuance	--491K	229.61%2.36M	142,400.00%1.43M	863.92%935K	--0	--0	-81.40%716K	-99.97%1K	-47.85%97K	60.45%499K
Cash from discontinued financing activities
Financing cash flow	765.68%2.7M	264.41%1.02M	394.75%1.12M	317.38%613K	-259.79%-310K	-166.45%-405K	-121.54%-621K	-112.44%-381K	-452.94%-282K	136.59%194K
Net cash flow
Beginning cash position	-57.63%3.55M	-72.16%8.37M	-44.88%6.29M	-59.70%6.1M	-64.74%6.81M	-72.16%8.37M	-28.18%30.05M	-65.50%11.41M	-60.60%15.15M	-52.61%19.32M
Current changes in cash	152.73%609K	78.65%-4.79M	13.99%-2.63M	100.10%4K	78.84%-1.01M	89.06%-1.16M	-83.09%-22.42M	-8.55%-3.06M	30.98%-4.05M	-132.93%-4.75M
Effect of exchange rate changes	61.31%-154K	-104.46%-33K	-806.25%-113K	-42.90%181K	-48.35%297K	-136.90%-398K	62.64%740K	107.92%16K	-36.60%317K	291.67%575K
End cash Position	-41.29%4M	-57.63%3.55M	-57.63%3.55M	-44.88%6.29M	-59.70%6.1M	-64.74%6.81M	-72.16%8.37M	-72.16%8.37M	-65.50%11.41M	-60.60%15.15M
Free cash flow	-202.90%-2.09M	73.54%-5.64M	-39.84%-3.77M	86.78%-501K	84.61%-683K	93.38%-689K	-90.80%-21.33M	-39.76%-2.7M	34.89%-3.79M	-109.09%-4.44M
Currency Unit	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data